Guidelines for the Management of Soft Tissue Sarcomas
Open accessThe DOI matches its Crossref record; 50 of the 50 references it cites were found in a registry or an index.
Abstract
These guidelines were drawn up following a consensus meeting of UK sarcoma specialists convened under the auspices of the British Sarcoma Group and are intended to provide a framework for the multidisciplinary care of patients with soft tissue sarcomas. The guidelines published by the European Society of Medical Oncology (ESMO) and the National Comprehensive Cancer Network (NCCN) were used as the basis for discussion and adapted according to UK clinical practice and local requirements. Note was also taken of the National Institute for Health and Clinical Excellence (NICE) improving outcomes guidance (IOG) for people with sarcoma and existing technology appraisals. The guidelines are not intended to challenge NICE guidance but discrepancies may exist where current guidance does not reflect an international standard of care owing to the ever-evolving nature of cancer treatment. It is acknowledged that these guidelines will require updating on a regular basis. An appendix lists the key recommendations which are summarised below. Any patient with a suspected soft tissue sarcoma should be referred to a diagnostic centre and managed by a specialist sarcoma multidisciplinary team. Surgical excision followed by post operative radiotherapy is the standard management of high grade limb sarcomas although occasionally amputation remains the only option. Pre-operative treatment with chemotherapy or radiotherapy should be considered for patients with borderline resectable tumours. Isolated limb perfusion may permit limb salvage in some cases where amputation is the only other option. Adjuvant chemotherapy is not routinely recommended but may be considered in certain specific situations. Regular follow up is recommended to assess local control and the development of metastatic disease. Single agent doxorubicin is the standard first line therapy for metastatic disease. Ifosfamide is an alternative if anthracyclines are contraindicated. Combination therapy may be considered in individual patients. Second line agents include ifosfamide, dacarbazine, trabectedin and the combination of gemcitabine + docetaxel. Surgical resection of local recurrence and pulmonary metastases should be considered in individual patients. There is specific guidance on the management of retroperitoneal and uterine sarcomas.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Pharmacological interventions for somatoform disorders in adults
Kleinstäuber, M., Witthöft, M., Steffanowski, A., van Marwijk, H., Hiller, W., & Lambert, M. J. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd010628.pub2 · Cited by 11,335
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K., & Mertens, F. (2002) · Lund University Publications (Lund University) · Cited by 4,469
A System for the Surgical Staging of Musculoskeletal Sarcoma
ENNEKING, W. F., SPANIER, S. S., & GOODMAN, M. A. (1980) · Clinical Orthopaedics and Related Research · doi:10.1097/00003086-198011000-00013 · Cited by 2,500
Benson, A. B., Abrams, T. A., Ben-Josef, E., Bloomston, P. M., Botha, J. F., Clary, B. M., Covey, A., Curley, S. A., D'Angelica, M. I., Davila, R., et al. (2009) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2009.0027 · Cited by 2,268
Pathology and genetics of tumours of soft tissue and bone
Fletcher, C. D. �., Unni, K. K., & Mertens, F. (2002) · Medical Entomology and Zoology · Cited by 2,073
O'Sullivan, B., Davis, A. M., Turcotte, R., Bell, R., Catton, C., Chabot, P., Wunder, J., Kandel, R., Goddard, K., Sadura, A., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)09292-9 · Cited by 1,598
Yang, J. C., Chang, A. E., Baker, A. R., Sindelar, W. F., Danforth, D. N., Topalian, S. L., DeLaney, T., Glatstein, E., Steinberg, S. M., Merino, M. J., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.1.197 · Cited by 1,541
(1997) · The Lancet · doi:10.1016/s0140-6736(97)08165-8 · Cited by 1,044
A system for the surgical staging of musculoskeletal sarcoma.
Enneking, W. F., Spanier, S. S., & Goodman, M. A. (1981) · PubMed · Cited by 1,001
Pervaiz, N., Colterjohn, N., Farrokhyar, F., Tozer, R., Figueredo, A., & Ghert, M. (2008) · Cancer · doi:10.1002/cncr.23592 · Cited by 987
Heterozygous Germ Line hCHK2 Mutations in Li-Fraumeni Syndrome
Bell, D. W., Varley, J. M., Szydlo, T. E., Kang, D. H., Wahrer, D. C. R., Shannon, K. E., Lubratovich, M., Verselis, S. J., Isselbacher, K. J., Fraumeni, J. F., et al. (1999) · Science · doi:10.1126/science.286.5449.2528 · Cited by 904
Maki, R. G., Wathen, J. K., Patel, S. R., Priebat, D. A., Okuno, S. H., Samuels, B., Fanucchi, M., Harmon, D. C., Schuetze, S. M., Reinke, D., et al. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.4117 · Cited by 742
Coindre, J.-M., Terrier, P., Guillou, L., Le Doussal, V., Collin, F., Ranch�re, D., Sastre, X., Vilain, M.-O., Bonichon, F., & N'Guyen Bui, B. (2001) · Cancer · doi:10.1002/1097-0142(20010515)91:10<1914::aid-cncr1214>3.0.co;2-3 · Cited by 740
Soft Tissue Sarcoma, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology
von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., Kane, J. M., et al. (2018) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2018.0025 · Cited by 736
Gastrosplenic Fistula From Hodgkin's Lymphoma
Seib, C. D., Rocha, F. G., Hwang, D. G., & Shoji, B. T. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.7695 · Cited by 735
Frustaci, S., Gherlinzoni, F., De Paoli, A., Bonetti, M., Azzarelli, A., Comandone, A., Olmi, P., Buonadonna, A., Pignatti, G., Barbieri, E., et al. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.5.1238 · Cited by 712
DAVIS, A., OSULLIVAN, B., TURCOTTE, R., BELL, R., CATTON, C., CHABOT, P., WUNDER, J., HAMMOND, A., BENK, V, & KANDEL, R. (2005) · Radiotherapy and Oncology · doi:10.1016/j.radonc.2004.12.020 · Cited by 710
Van Glabbeke, M., van Oosterom, A. T., Oosterhuis, J. W., Mouridsen, H., Crowther, D., Somers, R., Verweij, J., Santoro, A., Buesa, J., & Tursz, T. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.1.150 · Cited by 608
Demetri, G. D., Chawla, S. P., von Mehren, M., Ritch, P., Baker, L. H., Blay, J. Y., Hande, K. R., Keohan, M. L., Samuels, B. L., Schuetze, S., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.21.0088 · Cited by 538
[Hypercoagulability and exanthematous Mediterranean fever].
Vicente, V., Moraleda, J. M., Herrero, I., & Ruiz, R. (1991) · PubMed · Cited by 493
NF1 Gene and Neurofibromatosis 1
Rasmussen, S. A., & Friedman, J. M. (2000) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a010118 · Cited by 401
Differential sensitivity of liposarcoma subtypes to chemotherapy
Jones, R. L., Fisher, C., Al-Muderis, O., & Judson, I. R. (2005) · European Journal of Cancer · doi:10.1016/j.ejca.2005.07.023 · Cited by 354
Self-citationHand-Foot Syndrome After Dose-Dense Adjuvant Chemotherapy for Breast Cancer: A Case Series
Bardia, A., Loprinzi, C. L., & Goetz, M. P. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.06.1143 · Cited by 312
Soft Tissue Sarcoma, Version 2.2016, NCCN Clinical Practice Guidelines in Oncology
von Mehren, M., Randall, R. L., Benjamin, R. S., Boles, S., Bui, M. M., Conrad, E. U., Ganjoo, K. N., George, S., Gonzalez, R. J., Heslin, M. J., et al. (2016) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2016.0078 · Cited by 297
Davis, A. M., O’Sullivan, B., Bell, R. S., Turcotte, R., Catton, C. N., Wunder, J. S., Chabot, P., Hammond, A., Benk, V., Isler, M., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.03.084 · Cited by 278
Spurrell, E. L., Fisher, C., Thomas, J. M., & Judson, I. R. (2005) · Annals of Oncology · doi:10.1093/annonc/mdi082 · Cited by 245
Self-citationLeu, K. M., Ostruszka, L. J., Shewach, D., Zalupski, M., Sondak, V., Biermann, J. S., Lee, J. S.-J., Couwlier, C., Palazzolo, K., & Baker, L. H. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.043 · Cited by 241
Low-grade endometrial stromal sarcoma: hormonal aspects☆
Chu, M. C., Mor, G., Lim, C., Zheng, W., Parkash, V., & Schwartz, P. E. (2003) · Gynecologic Oncology · doi:10.1016/s0090-8258(03)00258-0 · Cited by 236
Current uses of isolated limb perfusion in the clinic and a model system for new strategies
Eggermont, A. M., de Wilt, J. H., & ten Hagen, T. L. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01141-0 · Cited by 235
Schlemmer, M., Reichardt, P., Verweij, J., Hartmann, J. T., Judson, I., Thyss, A., Hogendoorn, P. C. W., Marreaud, S., Glabbeke, M. V., & Blay, J. Y. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.07.037 · Cited by 233
Self-citationKaravasilis, V., Seddon, B. M., Ashley, S., Al‐Muderis, O., Fisher, C., & Judson, I. (2008) · Cancer · doi:10.1002/cncr.23332 · Cited by 214
Self-citationThe management of cancer in the older adolescent
Albritton, K., & Bleyer, W. A. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.09.013 · Cited by 198
Blay, J.-Y., van Glabbeke, M., Verweij, J., van Oosterom, A. T., Le Cesne, A., Oosterhuis, J. W., Judson, I., & Nielsen, O. S. (2003) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00480-x · Cited by 184
Self-citationBramwell, V., Anderson, D., Charette, M., & Sarcoma Disease Site Group (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003293 · Cited by 172
van Oosterom, A. T., Mouridsen, H. T., Nielsen, O. S., Dombernowsky, P., Krzemieniecki, K., Judson, I., Svancarova, L., Spooner, D., Hermans, C., Van Glabbeke, M., et al. (2002) · European Journal of Cancer · doi:10.1016/s0959-8049(02)00491-4 · Cited by 164
Self-citationSoft tissue sarcomas: ESMO Clinical Recommendations for diagnosis, treatment and follow-up
Casali, P. G., Jost, L., Sleijfer, S., Verweij, J., & Blay, J.-Y. (2009) · Annals of Oncology · doi:10.1093/annonc/mdp153 · Cited by 161
Zagars, G. K., Ballo, M. T., Pisters, P. W. T., Pollock, R. E., PATEL, S. R., & Benjamin, R. S. (2003) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)04510-8 · Cited by 147
Tzeng, C.-W. D., Fiveash, J. B., Popple, R. A., Arnoletti, J. P., Russo, S. M., Urist, M. M., Bland, K. I., & Heslin, M. J. (2006) · Cancer · doi:10.1002/cncr.22005 · Cited by 139
Staging Soft Tissue Sarcoma: Evolution and Change
Kotilingam, D., Lev, D. C., Lazar, A. J., & Pollock, R. E. (2006) · CA A Cancer Journal for Clinicians · doi:10.3322/canjclin.56.5.282 · Cited by 135
Adjuvant chemotherapy for localised resectable soft tissue sarcoma in adults
Sarcoma Meta‐analysis Collaboration (SMAC) ‐ see acknowledgement section for list of authors (2000) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd001419 · Cited by 127
Participation of adolescents with cancer in clinical trials
Ferrari, A., & Bleyer, A. (2007) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2006.11.005 · Cited by 108
Imaging strategy for detecting lung metastases at presentation in patients with soft tissue sarcomas
Christie-Large, M., James, S., Tiessen, L., Davies, A. M., & Grimer, R. J. (2008) · European Journal of Cancer · doi:10.1016/j.ejca.2008.06.004 · Cited by 85
Self-citationAggressive fibromatosis of the abdominal wall, limbs and limb girdles
Phillips, S. R., A’Hern, R., & Thomas, J. (2004) · British journal of surgery · doi:10.1002/bjs.4792 · Cited by 84
Hayes, A. J., Neuhaus, S. J., Clark, M. A., & Thomas, J. M. (2006) · Annals of Surgical Oncology · doi:10.1245/s10434-006-9040-x · Cited by 79
Birch, J. M., Alston, R. D., Quinn, M. J., & Kelsey, A. M. (2003) · European Journal of Cancer · doi:10.1016/j.ejca.2003.08.006 · Cited by 69
Gerrand, C., Billingham, L. J., Woll, P. J., & Grimer, R. J. (2007) · Sarcoma · doi:10.1155/2007/34128 · Cited by 67
Self-citationPalumbo, R., Palmeri, S., Antimi, M., Gatti, C., Raffo, P., Villani, G. M., & Toma, S. (1997) · Annals of Oncology · doi:10.1023/a:1008279426654 · Cited by 64
Long-Term Outcomes After Radiotherapy for Retroperitoneal and Deep Truncal Sarcoma
Feng, M. U.-S., Murphy, J. D., Griffith, K. A., Baker, L. H., Sondak, V. K., Lucas, D. R., McGinn, C. J., & Ray, M. E. (2007) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.02.041 · Cited by 58
Predictive variables detailing the recurrence rate of soft tissue sarcomas
Grobmyer, S. R., & Brennan, M. F. (2003) · Current Opinion in Oncology · doi:10.1097/00001622-200307000-00007 · Cited by 46
Cited by
UK guidelines for the management of soft tissue sarcomas
Dangoor, A., Seddon, B., Gerrand, C., Grimer, R., Whelan, J., & Judson, I. (2016) · Clinical Sarcoma Research · doi:10.1186/s13569-016-0060-4 · Cited by 477
Self-citationDeep Learning-Based Image Segmentation on Multimodal Medical Imaging
Guo, Z., Li, X., Huang, H., Guo, N., & Li, Q. (2019) · IEEE Transactions on Radiation and Plasma Medical Sciences · doi:10.1109/trpms.2018.2890359 · Cited by 440
Putative DNA/RNA helicase Schlafen-11 (SLFN11) sensitizes cancer cells to DNA-damaging agents
Zoppoli, G., Regairaz, M., Leo, E., Reinhold, W. C., Varma, S., Ballestrero, A., Doroshow, J. H., & Pommier, Y. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1205943109 · Cited by 369
Surgery in reference centers improves survival of sarcoma patients: a nationwide study
Blay, J.-Y., Honoré, C., Stoeckle, E., Meeus, P., Jafari, M., Gouin, F., Anract, P., Ferron, G., Rochwerger, A., Ropars, M., et al. (2019) · Annals of Oncology · doi:10.1093/annonc/mdz124 · Cited by 338
Management of sarcoma in the Asia-Pacific region: resource-stratified guidelines.
Lewin, J., Puri, A., Quek, R., Ngan, R., Alcasabas, A. P., Wood, D., & Thomas, D. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70475-3 · Cited by 44
Metadata
- Authors
- Grimer, R., Judson, I., Peake, D., & Seddon, B.
- Venue
- Sarcoma
- Publisher
- Hindawi Limited
- Published
- 2010
- Volume
- 2010
- Pages
- 1-15
- ISSN
- 1357-714X (ISSN-L)
- 1369-1643
- OpenAlex
- W2018153447
- Cited by
- 432
- References
- 50
- FWCI
- 21.40
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.